Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey-Reference-Cited by-同舟云学术

Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey

Published:2024-04-02 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Jarrot Pierre-André¹²^ORCID,Mirouse Adrien³⁴⁵,Ottaviani Sébastien⁶,Cadiou Simon⁷,Salmon Jean-Hugues⁸,Liozon Eric⁹,Parreau Simon⁹,Michaud Martin¹⁰,Terrier Benjamin¹¹,Gavand Pierre-Edouard¹²,Trefond Ludovic¹³,Lavoiepierre Virginie¹,Keraen Jeremy¹⁴,Rekassa Daniel¹⁵,Bouldoires Bastien¹⁶,Weitten Thierry¹⁷,Roche Damien¹⁸,Poulet Antoine¹⁹,Charpin Caroline¹⁸,Grobost Vincent²⁰,Hermet Marion²¹,Pallure Magali²²,Wackenheim Chloe²³,Karkowski Ludovic²⁴,Grumet Pierre¹⁷,Rogier Thomas²⁵,Belkefi Nabil²⁶,Pestre Vincent²⁷,Broquet Emilie²⁸,Leurs Amélie²⁹,Gautier Sophie³⁰,Gras Valérie³¹,Gilet Pierre³²,Holubar Jan³³,Sivova Nadia³⁴,Schleinitz Nicolas³⁵,Durand Jean-Marc³⁵,Castel Brice³⁶,Petrier Alexandre³⁷,Arcani Robin³⁸,Gramont Baptiste³⁹,Guilpain Philippe⁴⁰,Lepidi Hubert⁴¹,Weiller Pierre-Jean⁴²,Micallef Joelle⁴³,Saadoun David³⁴⁵,Kaplanski Gilles¹²

Affiliation:

1. Department of Internal Medicine and Clinical Immunology, Hôpital de La Conception, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France

2. Centre for Cardiovascular and Nutrition Research (C2VN), INRA 1260, INSERM UMR_S1263, Aix-Marseille University, Marseille, France

3. Department of Internal Medicine and Clinical Immunology, Centre de Référence des Maladies Auto-Immunes Systémiques Rares, Centre de Référence des Maladies Auto-Inflammatoires et de l’Amylose inflammatoire (CEREMAIA), Sorbonne Universités, Paris, France

4. INSERM, UMR_S 959 Lab, Immunology, Immunotherapeutics, Paris, France

5. DMU 3ID, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France

6. Department of Rheumatology, DMU Locomotion, Hôpital Bichat-Claude Bernard, APHP, Université de Paris, Paris, France

7. Department of Rheumatology, CHU de Rennes, Université de Rennes 1, Rennes, France

8. Department of Rheumatology, Hôpital de La Maison Blanche, Université de Reims, Reims, France

9. Department of Internal Medicine, Hôpital Universitaire de Limoges, Limoges, France

10. Department of Internal Medicine, Clinique Saint-Exupery, Toulouse, France

11. National Referral Center for Rare Systemic Autoimmune Disease, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre, Université Paris Cité, Paris, France

12. Department of Internal Medicine, Clinique Rhena, Strasbourg, France

13. Department of Internal Medicine, Hôpital Gabriel Montpied, Clermont-Ferrand, France

14. Department of Internal Medicine, Hôpital de Cornouaille, Quimper, France

15. Department of Rehabilitation, Centre Thermal, Greoux Les Bains, France

16. Department of Internal Medicine, Hôpital Louis Pasteur, Colmar, France

17. Department of Internal Medicine, Hôpital des Alpes du Sud, Gap, France

18. Department of Rheumatology, Hôpital Saint-Joseph, Marseille, France

19. Department of Internal Medicine, Hôpital Saint-Joseph, Marseille, France

20. Department of Internal Medicine, Hôpital Estaing, Clermont-Ferrand, France

21. Department of Internal Medicine, Hôpital de Vichy, Vichy, France

22. Department of Rheumatology, Hôpital de Cannes Simone Veil, Cannes, France

23. Department of Internal Medicine, Medipole Hôpital Privé, Villeurbanne, France

24. Department of Internal Medicine, Hôpital d’Instruction des Armées Sainte-Anne, Toulon, France

25. Department of Internal Medicine and Systemic Disease, Hôpital François Mitterand, Dijon, France

26. Department of Internal Medicine, CH de Melun, Melun, France

27. Department of Internal Medicine and Infectious Disease, CH d’Avignon, Avignon, France

28. General Practitioner, Bordeaux, France

29. Department of Internal Medicine and Infectious Disease, CH de Dunkerque, Dunkerque, France

30. Department of Pharmacology, centre régional de pharmacovigilance Nord Pas de Calais, CHRU de Lille, Lille, France

31. Department of Clinical Pharmacology, Centre régional de pharmacovigilance, service de pharmacologie clinique, CHU Amiens-Picardie, Amiens, France

32. Regional Center of Pharmacovigilance, CHRU de Nancy, Hôpital Central, Nancy, France

33. Department of Internal Medicine, CHU de Nîmes, Nîmes, France

34. Department of Internal Medicine, CH de Tourcoing, Tourcoing, France

35. Department of Internal Medicine, Hôpital de La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France

36. Department of Internal Medicine, CH de Tarbes, Tarbes, France

37. General Practitioner, Roquebrune sur Argens, France

38. Department of Internal Medicine and Therapeutics Department, Hôpital de La Timone, Marseille, France

39. Department of Internal Medicine, CHU de Saint-Etienne, Saint-Etienne, France

40. Department of Internal Medicine, CHU Saint-Eloi, Montpellier, France

41. Pathological Laboratory, Hôpital de La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France

42. Department of Onco-Hematology, Institut Paoli-Calmettes, Marseille, France

43. Department of Clinical Pharmacology and pharmacosurveillance, Regional Pharmacovigilance Center of Marseille, Hôpital de La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), Marseille, France

Funder

no funding

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2334084

Reference53 articles.

1. Clinical features of polymyalgia rheumatica and giant cell arteritis

2. Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: The first government-supported nationwide survey

3. The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population

4. Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects

5. COVID-19 vaccines adverse events: potential molecular mechanisms

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 in patients with interstitial lung disease;COVID-19: An Update;2024-09-01